102 related articles for article (PubMed ID: 29440770)
1. Anti-Helicobacter pylori activities of selected N-substituted cinnamamide derivatives evaluated on reference and clinical bacterial strains.
Klesiewicz K; Karczewska E; Nowak P; Skiba-Kurek I; Sito E; Pańczyk K; Koczurkiewicz P; Żelaszczyk D; Pękala E; Waszkielewicz AM; Budak A; Marona H; Gunia-Krzyżak A
J Antibiot (Tokyo); 2018 May; 71(5):543-548. PubMed ID: 29440770
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods.
Mishra KK; Srivastava S; Garg A; Ayyagari A
Curr Microbiol; 2006 Oct; 53(4):329-34. PubMed ID: 16972131
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides.
Pospisilova S; Kos J; Michnova H; Kapustikova I; Strharsky T; Oravec M; Moricz AM; Bakonyi J; Kauerova T; Kollar P; Cizek A; Jampilek J
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087309
[No Abstract] [Full Text] [Related]
4. Antibacterial activities of oxyprenylated chalcones and napthtoquinone against Helicobacter pylori.
Bodet C; Burucoa C; Rouillon S; Bellin N; Taddeo VA; Fiorito S; Genovese S; Epifano F
Nat Prod Commun; 2014 Sep; 9(9):1299-301. PubMed ID: 25918797
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori.
Park BS; Lee HK; Lee SE; Piao XL; Takeoka GR; Wong RY; Ahn YJ; Kim JH
J Ethnopharmacol; 2006 Apr; 105(1-2):255-62. PubMed ID: 16359837
[TBL] [Abstract][Full Text] [Related]
6. Anti-Helicobacter pylori activities of natural isopentenyloxycinnamyl derivatives from Boronia pinnata.
da Silva CR; Michel V; Genovese S; Prévost MC; Epifano F; Touati E
Nat Prod Commun; 2012 Oct; 7(10):1347-50. PubMed ID: 23157006
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.
Chimenti F; Bizzarri B; Bolasco A; Secci D; Chimenti P; Granese A; Carradori S; Rivanera D; Zicari A; Scaltrito MM; Sisto F
Bioorg Med Chem Lett; 2010 Aug; 20(16):4922-6. PubMed ID: 20630755
[TBL] [Abstract][Full Text] [Related]
8.
Chung JW; Kim SY; Park HJ; Chung CS; Lee HW; Lee SM; Kim I; Pak JH; Lee GH; Jeong JY
Gut Liver; 2017 Sep; 11(5):648-654. PubMed ID: 28750485
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori.
Glupczynski Y; Broutet N; Cantagrel A; Andersen LP; Alarcon T; López-Brea M; Mégraud F
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):549-52. PubMed ID: 12172749
[TBL] [Abstract][Full Text] [Related]
10. Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications.
Tanih NF; Okeleye BI; Naidoo N; Clarke AM; Mkwetshana N; Green E; Ndip LM; Ndip RN
S Afr Med J; 2010 Jan; 100(1):49-52. PubMed ID: 20429489
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.
Chimenti F; Bizzarri B; Bolasco A; Secci D; Chimenti P; Carradori S; Granese A; Rivanera D; Lilli D; Scaltrito MM; Brenciaglia MI
Eur J Med Chem; 2006 Feb; 41(2):208-12. PubMed ID: 16377035
[TBL] [Abstract][Full Text] [Related]
12. Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone.
Klesiewicz K; Karczewska E; Budak A; Marona H; Szkaradek N
J Antibiot (Tokyo); 2016 Nov; 69(11):825-834. PubMed ID: 27025351
[TBL] [Abstract][Full Text] [Related]
13. Trifluoromethylcinnamanilide Michael Acceptors for Treatment of Resistant Bacterial Infections.
Strharsky T; Pindjakova D; Kos J; Vrablova L; Smak P; Michnova H; Gonec T; Hosek J; Oravec M; Jendrzejewska I; Cizek A; Jampilek J
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499415
[TBL] [Abstract][Full Text] [Related]
14. Anti-Helicobacter pylori activity of bioactive components isolated from Hericium erinaceus.
Liu JH; Li L; Shang XD; Zhang JL; Tan Q
J Ethnopharmacol; 2016 May; 183():54-58. PubMed ID: 26364939
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives.
Chimenti F; Bizzarri B; Manna F; Bolasco A; Secci D; Chimenti P; Granese A; Rivanera D; Lilli D; Scaltrito MM; Brenciaglia MI
Bioorg Med Chem Lett; 2005 Feb; 15(3):603-7. PubMed ID: 15664821
[TBL] [Abstract][Full Text] [Related]
16. Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003.
Watanabe K; Tanaka A; Imase K; Tokunaga K; Sugano H; Kai A; Ishida H; Itoh T; Takahashi S
Helicobacter; 2005 Feb; 10(1):4-11. PubMed ID: 15691310
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity and postantibiotic effect of flurithromycin against Helicobacter pylori strains.
Fera MT; Giannone M; Pallio S; Tortora A; Blandino G; Carbone M
Int J Antimicrob Agents; 2001 Feb; 17(2):151-4. PubMed ID: 11165121
[TBL] [Abstract][Full Text] [Related]
18. PCR-RFLP detection of point mutations A2143G and A2142G in 23S rRNA gene conferring resistance to clarithromycin in Helicobacter pylori strains.
Klesiewicz K; Nowak P; Karczewska E; Skiba I; Wojtas-Bonior I; Sito E; Budak A
Acta Biochim Pol; 2014; 61(2):311-5. PubMed ID: 24927236
[TBL] [Abstract][Full Text] [Related]
19. Anti-Helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives.
Katsura Y; Tomishi T; Inoue Y; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
J Med Chem; 2000 Aug; 43(17):3315-21. PubMed ID: 10966750
[TBL] [Abstract][Full Text] [Related]
20. The role of active efflux in antibiotic - resistance of clinical isolates of Helicobacter pylori.
Falsafi T; Ehsani A; Niknam V
Indian J Med Microbiol; 2009; 27(4):335-40. PubMed ID: 19736403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
